ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine
ETNK1 mutations are recurrent in leukemia but how they contribute to oncogenesis is still unclear. Here, the authors show that ETNK1 mutations increase mitochondrial activity, ROS and H2AX levels and that these effects can be rescued upon phosphoethanolamine supplementation.
Guardado en:
Autores principales: | Diletta Fontana, Mario Mauri, Rossella Renso, Mattia Docci, Ilaria Crespiatico, Lisa M. Røst, Mi Jang, Antonio Niro, Deborah D’Aliberti, Luca Massimino, Mayla Bertagna, Giovanni Zambrotta, Mario Bossi, Stefania Citterio, Barbara Crescenzi, Francesca Fanelli, Valeria Cassina, Roberta Corti, Domenico Salerno, Luca Nardo, Clizia Chinello, Francesco Mantegazza, Cristina Mecucci, Fulvio Magni, Guido Cavaletti, Per Bruheim, Delphine Rea, Steen Larsen, Carlo Gambacorti-Passerini, Rocco Piazza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/001bd3e4deb94183af19e38c9741b285 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutation research.
Publicado: (1997) -
Mutation research.
Publicado: (1997) -
Mutation research.
Publicado: (1988) -
Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
por: Shujuan Wang, et al.
Publicado: (2020) -
The effects of mutational processes and selection on driver mutations across cancer types
por: Daniel Temko, et al.
Publicado: (2018)